OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VLMR59

Valmore Holding Sae

Diversified ChemicalsVerified

Valmore Holding Sae maintains a debt-to-equity ratio of 1.39, indicating a moderate reliance on debt financing, while its liquidity position is characterized as medium. The company holds $60.7 million in cash and equivalents, but this is offset by $712.4 million in long-term debt, resulting in a net cash position that is negative. The current ratio of 2.09 suggests the company has sufficient short-term assets to cover its short-term liabilities, supporting a stable working capital position. Profitability metrics show a return on equity (ROE) of 31.54% and a return on assets (ROA) of 10.07%, both of which exceed the typical thresholds for the Diversified Chemicals industry. The operating margin, calculated as operating income of $273.3 million on revenue of $684.9 million, stands at 40.0%, which is significantly higher than the industry median, indicating strong operational efficiency. The company's revenue is not segmented by product or geography in the available data, but its exposure to geographic markets is not explicitly detailed. Given the nature of the Diversified Chemicals industry, it is likely that Valmore serves multiple regions, though the extent of geographic diversification remains unclear. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The current fiscal year revenue of $684.9 million reflects a consistent performance, and the absence of a clear growth driver or decline factor suggests a steady-state operating model. Risk factors include a medium liquidity risk due to the company's reliance on long-term debt and the potential for interest rate volatility to impact borrowing costs. The risk assessment also notes a low dilution risk, as the number of shares outstanding has not changed between basic and diluted figures, indicating no imminent share issuance or dilution pressure. Recent events include analyst price targets ranging from $0.95 to $1.70, with a mean of $1.28 and a median of $1.20. Analysts have issued two "Buy" recommendations and no "Strong Buy" or "Hold" ratings, suggesting a cautiously optimistic outlook on the company's valuation and performance.

30-day price · VLMR-0.04 (-6.1%)
Low$0.66High$0.74Close$0.66As of25 May, 00:00 UTC
Profile
CompanyValmore Holding Sae
TickerVLMR.CA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Valmore Holding Sae operates in the Diversified Chemicals industry, producing and distributing a range of chemical products, and generates revenue primarily through the sale of these products to industrial and commercial customers.

Classification. Valmore Holding Sae is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry, with a confidence level of 0.92 based on verified market data.

Valmore Holding Sae maintains a debt-to-equity ratio of 1.39, indicating a moderate reliance on debt financing, while its liquidity position is characterized as medium. The company holds $60.7 million in cash and equivalents, but this is offset by $712.4 million in long-term debt, resulting in a net cash position that is negative. The current ratio of 2.09 suggests the company has sufficient short-term assets to cover its short-term liabilities, supporting a stable working capital position. Profitability metrics show a return on equity (ROE) of 31.54% and a return on assets (ROA) of 10.07%, both of which exceed the typical thresholds for the Diversified Chemicals industry. The operating margin, calculated as operating income of $273.3 million on revenue of $684.9 million, stands at 40.0%, which is significantly higher than the industry median, indicating strong operational efficiency. The company's revenue is not segmented by product or geography in the available data, but its exposure to geographic markets is not explicitly detailed. Given the nature of the Diversified Chemicals industry, it is likely that Valmore serves multiple regions, though the extent of geographic diversification remains unclear. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The current fiscal year revenue of $684.9 million reflects a consistent performance, and the absence of a clear growth driver or decline factor suggests a steady-state operating model. Risk factors include a medium liquidity risk due to the company's reliance on long-term debt and the potential for interest rate volatility to impact borrowing costs. The risk assessment also notes a low dilution risk, as the number of shares outstanding has not changed between basic and diluted figures, indicating no imminent share issuance or dilution pressure. Recent events include analyst price targets ranging from $0.95 to $1.70, with a mean of $1.28 and a median of $1.20. Analysts have issued two "Buy" recommendations and no "Strong Buy" or "Hold" ratings, suggesting a cautiously optimistic outlook on the company's valuation and performance.
Key takeaways
  • Valmore Holding Sae has a strong ROE of 31.54% and ROA of 10.07%, outperforming typical industry benchmarks.
  • The company maintains a current ratio of 2.09, indicating a stable short-term liquidity position.
  • Despite a debt-to-equity ratio of 1.39, the company is not currently facing dilution risk.
  • Analysts have assigned a mean price target of $1.28, with two "Buy" recommendations.
  • The company's revenue and operating performance suggest a steady-state model with no significant growth or decline expected.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$684.9M
Gross profit$236.5M
Operating income$273.3M
Net income$161.2M
R&D
SG&A
D&A
SBC
Operating cash flow$103.8M
CapEx-$45.0M
Free cash flow$112.5M
Total assets$1.60B
Total liabilities$1.09B
Total equity$511.0M
Cash & equivalents$60.7M
Long-term debt$712.4M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$511.0M
Net cash-$651.7M
Current ratio2.1
Debt/Equity1.4
ROA10.1%
ROE31.5%
Cash conversion64.0%
CapEx/Revenue-6.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 83 companies
MetricVLMRActivity
Op margin39.9%6.3% medp25 2.1% · p75 9.6%top quartile
Net margin23.5%3.3% medp25 0.2% · p75 6.4%top quartile
Gross margin34.5%23.5% medp25 13.2% · p75 31.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-6.6%-5.5% medp25 -11.2% · p75 -3.8%below median
Debt / equity139.0%42.1% medp25 16.7% · p75 82.4%top quartile
Observations
IR observations
Mean price target1.28 USD
Median price target1.20 USD
High price target1.70 USD
Low price target0.95 USD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.14 USD
Last actual EPS0.11 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 03:10 UTC#e77bd49e
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 22:56 UTCJob: a986ba81